$5.66
-0.0800 (-1.39%)
At Close: Jun 22, 2026
LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference
08:00am, Monday, 16'th Aug 2021
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q2 2021 Results - Earnings Call Transcript
05:27am, Monday, 09'th Aug 2021
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q2 2021 Results - Earnings Call Transcript
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q1 2021 Results - Earnings Call Transcript
03:28pm, Sunday, 09'th May 2021
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q1 2021 Results - Earnings Call Transcript
LENSAR's (LNSR) CEO Nick Curtis on Q4 2020 Results - Earnings Call Transcript
01:21pm, Wednesday, 10'th Mar 2021
LENSAR's (LNSR) CEO Nick Curtis on Q4 2020 Results - Earnings Call Transcript
LENSAR to Present at Two Upcoming Investor Conferences
08:00am, Monday, 08'th Feb 2021
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
Sign In
Buy LNSR